INCR

Intercure Ltd. Ordinary Shares (INCR)

Stock · NASDAQ · Health Care

$5.78as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$0.782688
Industry
Biotechnology: Pharmaceutical Preparations

About INCR

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
285

Fundamentals

1-day range
$0.9307$0.99
Market cap
$54.80M
P/E (trailing)
P/E (forward)
-0.67
EPS (trailing)
$-0.22
Dividend yield
Beta
0.57
Avg. volume
47.1K
52-week range
$0.68$1.71
Next earnings: May 15, 2023 · EPS estimate $0.01confirmed

Intercure Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • INCR
    Intercure Ltd. Ordinary Shares
    $5.78
    ▲ 1.76%
    Market cap $54.80MP/E
    $0.68$1.71
  • IMMP
    Immutep Limited American Depositary Shares
    $0.3848
    ▲ 1.26%
    Market cap $55.21MP/E
    $0.028$0.47
  • SDEV
    Stablecoin Development Corporation Common Stock
    $0.93
    ▼ 5.10%
    Market cap $52.64MP/E
    $0.96$99.75
  • RNXT
    RenovoRx Inc. Common Stock
    $1.68
    ▲ 13.18%
    Market cap $51.86MP/E
    $0.7006$1.56
  • SCYX
    SCYNEXIS Inc. Common Stock
    $5.44
    ▼ 1.45%
    Market cap $51.64MP/E
    $3.53$10.48
  • DWTX
    Dogwood Therapeutics Inc. Common Stock
    $2.6
    ▲ 12.07%
    Market cap $58.85MP/E 1.84
    $1.28$9.5
  • XLO
    Xilio Therapeutics Inc. Common Stock
    $9
    ▼ 0.22%
    Market cap $60.95MP/E
    $6.47$12.74

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.